Literature DB >> 21232116

An operative case of hepatic pseudolymphoma difficult to differentiate from primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Michihiro Hayashi1, Noboru Yonetani, Fumitoshi Hirokawa, Mitsuhiro Asakuma, Katsuhiko Miyaji, Atsushi Takeshita, Kazuhiro Yamamoto, Hironori Haga, Takayuki Takubo, Nobuhiko Tanigawa.   

Abstract

Hepatic pseudolymphoma (HPL) and primary hepatic marginal zone B cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) are rare diseases and the differential diagnosis between these two entities is sometimes difficult. We herein report a 56-year-old Japanese woman who was pointed out to have a space occupying lesion in the left lateral segment of the liver. Hepatitis viral-associated antigen/antibody was negative and liver function tests including lactic dehydrogenase, peripheral blood count, tumor markers and soluble interleukin-2 receptor were all within normal limit. Imaging study using computed tomography and magnetic resonance imaging were not typical for hepatocellular carcinoma, cholangiocarcinoma, or other metastatic cancer. Fluorodeoxyglucose-positron emission tomography examination integrated with computed tomography scanning showed high standardized uptake value in the solitary lesion in the liver. Under a diagnosis of primary liver neoplasm, laparoscopic-assisted lateral segmentectomy was performed. Liver tumor of maximal 1.0 cm in diameter was consisted of aggregation of lymphocytes of predominantly B-cell, containing multiple lymphocyte follicles positive for CD10 and bcl-2, consistent with a diagnosis of HPL rather than MALT lymphoma, although a definitive differentiation was pending. The background liver showed non-alcoholic fatty liver disease/early non-alcoholic steatohepatitis. The patient is currently doing well with no sign of relapse 13 months after the surgery. Since the accurate diagnosis is difficult, laparoscopic approach would provide a reasonable procedure of diagnostic and therapeutic advantage with minimal invasiveness for patients. Considering that the real nature of this entity remains unclear, vigilant follow-up of patient is essential.

Entities:  

Mesh:

Year:  2011        PMID: 21232116      PMCID: PMC3033353          DOI: 10.1186/1477-7819-9-3

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  42 in total

1.  Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C.

Authors:  Shugo Mizuno; Shuji Isaji; Masami Tabata; Shinji Uemoto; Hiroshi Imai; Katsuya Shiraki
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

2.  [A case of MALT lymphoma of the liver treated by RFA and Rituximab].

Authors:  Maho Hamada; Yoshinori Tanaka; Yuichi Kobayashi; Eiji Takeshita; Kouji Joko
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2006-06

3.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

4.  Primary hepatic B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  C M Kirk; D Lewin; J Lazarchick
Journal:  Arch Pathol Lab Med       Date:  1999-08       Impact factor: 5.534

5.  Hepatic reactive lymphoid hyperplasia in a patient with primary biliary cirrhosis.

Authors:  Mitsuaki Ishida; Tamio Nakahara; Yousuke Mochizuki; Tomoyuki Tsujikawa; Akira Andoh; Yasuharu Saito; Hiroshi Yamamoto; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Hepatol       Date:  2010-10-27

6.  Primary lymphoma of the liver in the acquired immunodeficiency syndrome.

Authors:  D Caccamo; N K Pervez; A Marchevsky
Journal:  Arch Pathol Lab Med       Date:  1986-06       Impact factor: 5.534

Review 7.  Pseudolymphoma of the liver associated with primary biliary cirrhosis: a case report and review of literature.

Authors:  Toshihide Okada; Hiroshi Mibayashi; Kenkei Hasatani; Yoshiaki Hayashi; Shigetsugu Tsuji; Yoshibumi Kaneko; Masashi Yoshimitsu; Takashi Tani; Yoh Zen; Masakazu Yamagishi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 8.  Primary non-Hodgkin's lymphoma of the liver.

Authors:  K I Lei
Journal:  Leuk Lymphoma       Date:  1998-04

Review 9.  Hepatic pseudolymphoma: a clinicopathological study of five cases and review of the literature.

Authors:  Yoh Zen; Takahiko Fujii; Yasuni Nakanuma
Journal:  Mod Pathol       Date:  2009-11-13       Impact factor: 7.842

Review 10.  Histiocyte-rich reactive lymphoid hyperplasia of the liver: unusual morphologic features.

Authors:  Ho Sung Park; Kyu Yun Jang; Young Kon Kim; Baik Hwan Cho; Woo Sung Moon
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

View more
  8 in total

1.  Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge.

Authors:  Yong Kyong Kwon; Reena C Jha; Kambiz Etesami; Thomas M Fishbein; Metin Ozdemirli; Chirag S Desai
Journal:  World J Hepatol       Date:  2015-11-18

2.  Reactive lymphoid hyperplasia of the liver mimicking hepatocellular carcinoma: incidental finding of two cases.

Authors:  Ang Lv; Wendy Liu; Hong-Gang Qian; Jia-Hua Leng; Chun-Yi Hao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Primary hepatic mucosa-associated lymphoid tissue lymphoma: case report and literature review.

Authors:  Zhengqi Fu; Lixia Wu; Jiaming Chen; Qichang Zheng; Ping Li; Li Zhang; Chuanming Zhu; Zhengshou Rao; Shaobo Hu
Journal:  Int J Clin Exp Pathol       Date:  2021-03-01

4.  Primary hepatic marginal zone B cell lymphoma : a case report and review of the literature.

Authors:  Young-Dong Yu; Dong-Sik Kim; Geon-Young Byun; Jeong-Hyeon Lee; In-Sun Kim; Chung-Yun Kim; Young-Chul Kim; Sung-Ock Suh
Journal:  Indian J Surg       Date:  2012-07-15       Impact factor: 0.656

5.  Primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and literature review.

Authors:  Shigeyuki Nagata; Norifumi Harimoto; Kiyoshi Kajiyama
Journal:  Surg Case Rep       Date:  2015-09-24

6.  Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography.

Authors:  Kazuhiro Suzumura; Etsuro Hatano; Toshihiro Okada; Yasukane Asano; Naoki Uyama; Seikan Hai; Ami Kurimoto; Kentaro Nonaka; Tohru Tsujimura; Jiro Fujimoto
Journal:  Case Rep Gastroenterol       Date:  2017-12-21

7.  A case of reactive lymphoid hyperplasia of the liver in a patient with autoimmune hepatitis.

Authors:  Hiroki Kanno; Hisamune Sakai; Toru Hisaka; Satoki Kojima; Ryuta Midorikawa; Shogo Fukutomi; Yoriko Nomura; Yuichi Goto; Toshihiro Sato; Munehiro Yoshitomi; Ryuichi Kawahara; Koji Okuda
Journal:  Surg Case Rep       Date:  2020-05-04

8.  Diffusion-weighted imaging might be useful for reactive lymphoid hyperplasia diagnosis of the liver: A case report.

Authors:  Taro Tanaka; Kazuhiro Saito; Daisuke Yunaiyama; Jun Matsubayashi; Yuichi Nagakawa; Maki Tanigawa; Toshitaka Nagao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.